Shemesh Shay 4
4 · Nuvectis Pharma, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Award
Common Stock
2024-01-03+130,000→ 1,491,955 total
Footnotes (2)
- [F1]The restricted stock will vest according to the following schedule: one-third on each of 01/3/2025, 01/3/2026, and 01/3/2027.
- [F2]Includes 353,399 shares of restricted stock.